ERA Biotech is a provider of biotechnology research and products. They use their proprietary technologies, Zera and Splittera, to develop and market breakthrough innovations for existing enzymes, recombinant and plasmid DNA vaccines, and protein-cleavage and purification systems. Their Zera and StorPro tools enable performance gains in eukaryotic culture systems used for producing protein drugs and other biological products. ERA Biotech also licenses their cell-based biomanufacturing technologies.